DE69001038T2 - Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen. - Google Patents

Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen.

Info

Publication number
DE69001038T2
DE69001038T2 DE9090401205T DE69001038T DE69001038T2 DE 69001038 T2 DE69001038 T2 DE 69001038T2 DE 9090401205 T DE9090401205 T DE 9090401205T DE 69001038 T DE69001038 T DE 69001038T DE 69001038 T2 DE69001038 T2 DE 69001038T2
Authority
DE
Germany
Prior art keywords
cerbrovascular
disorders
treating
aromatic amino
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090401205T
Other languages
English (en)
Other versions
DE69001038D1 (de
Inventor
Bernard Pourrias
Residence Gambetta Ward
Raphael Santamaria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Publication of DE69001038D1 publication Critical patent/DE69001038D1/de
Application granted granted Critical
Publication of DE69001038T2 publication Critical patent/DE69001038T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
DE9090401205T 1989-05-05 1990-05-04 Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen. Expired - Fee Related DE69001038T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8905988A FR2646670A1 (fr) 1989-05-05 1989-05-05 Utilisation de derives aminoalkoxy aromatiques pour le traitement des troubles du systeme cerebrovasculaire

Publications (2)

Publication Number Publication Date
DE69001038D1 DE69001038D1 (de) 1993-04-15
DE69001038T2 true DE69001038T2 (de) 1993-08-05

Family

ID=9381445

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090401205T Expired - Fee Related DE69001038T2 (de) 1989-05-05 1990-05-04 Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen.

Country Status (6)

Country Link
US (1) US5132302A (de)
EP (1) EP0396474B1 (de)
JP (1) JPH02295920A (de)
AT (1) ATE86485T1 (de)
DE (1) DE69001038T2 (de)
FR (1) FR2646670A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
AUPS110302A0 (en) * 2002-03-14 2002-04-18 Biomolecular Research Institute Limited Novel chalcone derivatives and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2518992A1 (fr) * 1981-12-24 1983-07-01 Delalande Sa Nouveaux derives aminoalcoxy aromatiques, leur procede de preparation et leur application en therapeutique
GR78370B (de) * 1981-12-24 1984-09-26 Delalande Sa

Also Published As

Publication number Publication date
FR2646670A1 (fr) 1990-11-09
EP0396474B1 (de) 1993-03-10
DE69001038D1 (de) 1993-04-15
US5132302A (en) 1992-07-21
JPH02295920A (ja) 1990-12-06
EP0396474A1 (de) 1990-11-07
ATE86485T1 (de) 1993-03-15

Similar Documents

Publication Publication Date Title
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
ATE249228T1 (de) Verwendung von polyallylamin-polymeren zur herstellung eines medikamentes zur behandlung von hypercholesterolemia
DE69326395T2 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
ATE162715T1 (de) Verwendung von schwefel enthaltenden carbonsäuren zur bekämpfung von pathophysiologisch bedingten erregungsstörungen
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ATE91287T1 (de) N-hydroxypropylisopropylaether-derivate des chitosans und diese enthaltende kosmetische mittel.
RU94019425A (ru) Производные изатиноксима, способ их получения, фармацевтическая композиция и способ лечения
DE3888340T2 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
NO895267D0 (no) Svovelinneholdende heterocykliske forbindelser.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
DE69001038T2 (de) Verwendung von aromatischen aminoalkoxyderivaten zur behandlung zerebrovaskulaerer stoerungen.
DE69209128D1 (de) Verwendung von Indazol-Methoxyalkansäure zur Herstellung eines Arzneimittels zur Behandlung von Autoimmunkrankheiten
ATE71099T1 (de) Calcium-4,6-dioxo-4h-pyrano(3,2-g>-chinolin-2,8 dicarboxylat-derivat, verfahren zu seiner herstellung und dieses enthaltende zusammensetzungen.
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
ATE31022T1 (de) Verwendung von 4,5'-azo-bis-salicylsaeure zur herstellung eines arzneimittels zur behandlung entzuendlicher darmkrankheiten.
DE69415757T2 (de) Zusammensetzung zur Vorbeugung und Behandlung von Myopie
ZA924118B (en) Isatineoxime derivatives, their preparation and use.
ES501744A0 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: SYNTHELABO, LE PLESSIS ROBINSON, FR

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee